texas oncology more breakthroughs. more victories
Some of our cancer centers may have important notifications found on the location page. View More Important Notifications x

Rebecca Fisher, M.D.

Rebecca Fisher, M.D. Photo

Provider Type: Physician

Board Certifications:
  • Neuro Oncology
  • Neurology



  • Fellowship in Neuro-Oncology
    Memorial Sloan Kettering Cancer Center, New York, NY
  • Residency in Neurology, Chief Resident
    University of Massachusetts Medical School, Worcester, MA
  • Internship in Internal Medicine
    Saint Vincent Hospital, Worcester, MA
  • Medical Doctorate
    The Warren Alpert Medical School of Brown University, Providence, RI and Geisel School of Medicine at Dartmouth, Hanover, NH


  • Adjuvant Therapy for Patients with Newly Diagnosed Glioblastoma Multiforme

    Nova Science Publishers, 2015

  • Management of Isolated Leptomeningeal Metastasis: Initial and Sole Site of Recurrence in a Patient with Early-stage Breast Cancer

    International Cancer Conference Journal, 2015

  • Therapeutic Plasma Exchange in a Patient with Paraneoplastic variant Stiff Person Syndrome

    American Association of Blood Banks, 2014 Annual Meeting, 2014

  • Radiation Exposure as a Link to Primary Ocular Diffuse Large B-cell Lymphoma

    American Society of Clinical Oncology (ASCO), 2014 Annual Meeting, 2014

  • Route of Intra-cerebrospinal Fluid Chemotherapy Administration and Efficacy of Therapy in Neoplastic Meningitis

    Cancer, 2010

Show all Publications
  • Leptomeningeal Metastases in Breast Cancer

    Diseases of the Breast, 2008

  • Phase II Trial of High-Dose Intravenous Methotrexate, Rituxan, and Intra-CSF DepoCyt in Patients with Newly Diagnosed Primary CNS Lymphoma

    Journal of Neuro-Oncology, 2007

  • Interaction between Route of Intra-CSF Chemotherapy Administration and Efficacy of Therapy in Patients with Neoplastic Meningitis

    Neurology, 2006

  • Potential Efficacy of Somatostatin for Treatment of Recurrent Meningiomas

    Neurology, 2006

Research Interest

  • Stem Cell Radiotherapy and temozolomide for Newly Diagnosed High Grade Glioma; prospective phase I/II trial co-investigator (IRB approved, NCT02039778)
  • Concurrent Bevacizumab and re-irradiation versus Bevacizumab alone as treatment for recurrent glioblastoma; randomized phase II trial co-investigator (RTOG 1205, NCT01730950)
  • Cabozantinib in Combination with Temozolomide and Radiation Therapy in the Initial Treatment of Adults with Glioblastoma; phase I trial co-investigator (IRB approved, NCT00960492)
  • Multiple Doses and Regimens of XL184 (Cabozantinib) in Subjects with Grade IV Astrocytic Tumors in First or Second Relapse; phase II trial co-investigator (IRB approved, NCT01068782)

Medical Practice

  • Mount Sinai Health System, New York, NY (August 2009 – October 2017)